OGG1 and hepatocellular carcinoma: Overall, we demonstrated that RBM39 regulated OGG1 stabilisation and improved BER efficiency, suggesting that combining the RBM39 degradant indisulam with the oxidising agent KBrO<sub>3</sub> could be an emerging strategy for HCC treatment.